We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
-12.08%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.39B
AUM Growth
-$257M
(-16%)
Cap. Flow
-$58.2M
Cap. Flow
% of AUM
-4.2%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
+$58.2M |
Sector Composition
| Rank | Sector | Weight |
|---|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q2 2015 Portfolio in Review
As of Q2 2015, Crestline Management held 1 position worth $1.39B, down 16% from $1.64B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Crestline Management withdrew a net $58.2M in Q2 2015, reducing 1 holding. Its largest reduction was Juno Therapeutics, Inc., cutting an estimated $58.2M.
- Crestline Management's biggest Q2 2015 reduction was Juno Therapeutics, Inc., cutting an estimated $58.2M.
- Crestline Management's ten largest holdings make up 100% of its $1.39B portfolio in Q2 2015.
- Crestline Management opened 0 new positions and closed 0 in Q2 2015.
- Crestline Management's portfolio value fell 16% quarter-over-quarter to $1.39B.
Based on Crestline Management's 13F filing for Q2 2015, filed 17 Jul 2015.